好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Cerebrovascular Disease: Stroke Prevention

Tuesday 04/12/11
03:00 PM - 04:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Cerebrovascular Disease and Interventional Neurology
No CME available
Event Timeline
03:00 PM - 04:30 PM Abstract 001 - Improved Prognosis of Medically Treated Hemodynamic Cerebral Ischemia Is Associated with More Lipid-Lowering Therapy
03:00 PM - 04:30 PM Abstract 002 - The Phosphodiesterase Inhibitor Cilostazol Can Induce the Regression of Carotid Intima-Media Thickness in Symptomatic Patients
03:00 PM - 04:30 PM Abstract 003 - Therapeutic Implications of Transthoracic Ecochardiography in Transient Ischaemic Attack
03:00 PM - 04:30 PM Abstract 004 - Occult Atrial Fibrillation among Subtypes of Ischemic Stroke and Transient Ischemic Attack
03:00 PM - 04:30 PM Abstract 005 - Factors Supportive of a Diagnosis of Paradoxical Embolism in Patients with Cryptogenic Stroke and Patent Foramen Ovale Are Not Associated with Radiological Markers of Recurrent Stroke
03:00 PM - 04:30 PM Abstract 006 - Is Acute Hospitalization Needed for Patients Presenting with a Transient Ischemic Attack? An Analysis of 400 Consecutive Patients
Faculty Disclosures
Harold P. Adams, Jr., MD, FAAN The institution of Dr. Adams has received research support from NINDS.
William J. Powers, MD, FAAN Dr. Powers has a non-compensated relationship as a Chair of the Writing Group for Acute Ischemic Stroke Guidelines with American Heart Association that is relevant to AAN interests or activities.
Teepu Siddique, MD, FAAN No disclosure on file
Yves Samson, MD No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
David E. Thaler, MD, PhD, FAAN Dr. Thaler has nothing to disclose.
Mustapha A. Ezzeddine, MD, FAAN The institution of Dr. Ezzeddine has received research support from NIH.
Cheryl Bushnell, MD, MHS Dr. Bushnell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZZ Biotech. The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from AHRQ. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
No disclosure on file
Sophie Crozier No disclosure on file
Anne Leger No disclosure on file
Kevin N. Sheth, MD, FAAN Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Michael Obadia, MD No disclosure on file
Charlotte Rosso No disclosure on file
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Patricia M. Riccio, MD No disclosure on file
Colin Derdeyn, MD The institution of Dr. Derdeyn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. The institution of Dr. Derdeyn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNO. The institution of Dr. Derdeyn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Silk Road. Dr. Derdeyn has stock in Pulse Therapeutics. Dr. Derdeyn has received publishing royalties from a publication relating to health care.
Sandrine Deltour, MD No disclosure on file
Seon Hee Bu, MD No disclosure on file
Christine Pires No disclosure on file
Sung Hyuk Heo, MD No disclosure on file
Haralabos Zacharatos, MD Dr. Zacharatos has nothing to disclose.
Taha Bali, MD No disclosure on file
Mushtaq H. Qureshi, MD No disclosure on file
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
William R. Clarke, PhD No disclosure on file
Aaron C. Lasker, MD Dr. Lasker has nothing to disclose.
Yann L'Hermitte No disclosure on file